Clinical Trials Directory

Trials / Conditions / Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8

Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8

9 registered clinical trials studyying Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingPembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adeno
NCT05041153
M.D. Anderson Cancer CenterEARLY_Phase 1
RecruitingRamucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Adv
NCT04660760
Academic and Community Cancer Research UnitedPhase 2
RecruitingTrifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Color
NCT04511039
Roswell Park Cancer InstitutePhase 1
Active Not RecruitingTesting the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Eso
NCT04460937
National Cancer Institute (NCI)Phase 1
RecruitingAvapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Sol
NCT04771520
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingPembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer
NCT04522336
M.D. Anderson Cancer CenterPhase 1
RecruitingRadiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
NCT04221893
University of California, San FranciscoN/A
Active Not RecruitingPaclitaxel for the Treatment of Gastric or Gastroesophageal Cancer
NCT04220827
M.D. Anderson Cancer CenterPhase 1
CompletedIRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Ga
NCT03918499
City of Hope Medical CenterPhase 1 / Phase 2